ULURU Repors Initial Pharmacoeconomic Data Demonstrates Cost Benefits Of Altrazeal
ULURU (OTC: ULUR) provides an update on the pharmacoeconomic analysis being conducted in Europe on Altrazeal ® , the Company's innovative wound dressing. The analysis is being conducted on defined-wound types and sizes, where there is a full thickness tissue loss. It is anticipated that the first results of this ongoing analysis will be completed prior to the ... More
April, 01ULURU Retires Convertible Debt
ULURU (OTC: ULUR) has made the final payment on the Inter-Mountain Capital Corporation ("Inter-Mountain") Secured Convertible Note. Under the terms of the Convertible Note, ULURU exercised their option to offset the principal and ... More
April 18 MiningCangold Signs Formal Option Agreement on Advanced Stage Gold-Silver Project in Mexico
Cangold (OTC: CGLJF; TSX-V: CLD) has signed the formal option agreement ...
April 17 MiningScorpio Gold Reports 2013 Q4 and Year-End Results
Scorpio Gold (OTC: SRCRF; TSX-V: SGN) reported financial results for ...
April 14 HealthcareMRI Interventions Update - Cook Children's Hospital Highlights ClearPoint(R) System on ABC Affiliate
MRI Interventions Update (OTCQB: MRIC) - ClearPoint™/Asleep DBS ...
April 14 MiningScorpio Gold Reports Initial Results from 2014 Expansion Drilling
Scorpio Gold (OTC: SRCRF; TSX-V: SGN) reports initial results from its ...
April 11 MiningArianne Phosphate Chosen as Top 20 Socially Responsible Juniors in 2013 by MacCormick's
Arianne Phosphate (TSX-V: DAN) (OTCBB: DRRSF), a development-stage ...
April 11 HealthcareSirona Biochem Investor Webinar and Q&A - April 15, 2014 @ 2pm PDT
VANCOUVER, BC - Sirona Biochem Corp. (OTCQX: SRBCF) (TSX-V: SBM) ...
- News & Blogs
- Publications & Downloads
- About Torrey Hills Capital
- Newsletter Signup